LMR Partners LLP: PYPL position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of LMR Partners LLP on PYPL, newest first. How the timeline and the estimate are built.
LMR Partners LLP held 20,021 PYPL shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 20,021 sharesChange vs previous 13F -49 shares
0.01% of the 13F portfolio, value $864,507.
13F-HR 0001578621-26-000147 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 20,070 sharesChange vs previous 13F -563 shares
0.01% of the 13F portfolio, value $907,766.
13F-HR 0001578621-26-000093 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 20,633 sharesChange vs previous 13F +16,589 shares
0.01% of the 13F portfolio, value $1,204,554.
13F-HR 0001578621-26-000003 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 4,044 sharesChange vs previous 13F +1,332 shares
<0.01% of the 13F portfolio, value $271,191.
13F-HR 0001578621-25-000014 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 2,712 sharesChange vs previous 13F -14,626 shares
<0.01% of the 13F portfolio, value $201,556.
13F-HR 0002069324-25-000006 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 17,338 sharesChange vs previous 13F not available
0.02% of the 13F portfolio, value $1,131,305.
13F-HR 0001578621-25-000009 filed by LMR Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).